updated analysis of the maia trial: long-term safety and efficacy data
Published 1 year ago • 330 plays • Length 2:37Download video MP4
Download video MP3
Similar videos
-
1:08
long term follow-up results from the phase iii maia trial in myeloma
-
1:53
updated analysis of maia: d-rd continues to beat rd in transplant-ineligible ndmm
-
3:08
frailty subgroup analysis of the maia trial
-
2:21
the role of daratumumab in the treatment of myeloma and insights into the maia trial
-
1:06
long-term outcomes of the ocean study: melflufen is superior to pomalidomide in r/r myeloma
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
2:23
the significance of variant allele frequency in patients with sf3b1-mutated mds
-
6:23
results of maintenance therapy in high-risk myeloma patients | ajay nooka, md, mph, facp | asco 2023
-
4:03
maia and alcyone: follow-up of daratumumab in multiple myeloma
-
2:05
updated phase i results from sgnbcma-001 study of sea-bcma in patients with r/r multiple myeloma
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
4:45
a first-in-human trial of linvoseltamab (regn5458) in r/r myeloma: updated phase i data
-
1:22
long-term follow-up results of tourmaline-mm2: ird vs pbo-rd in multiple myeloma
-
3:56
real-world analysis of treatment patterns and outcomes in newly diagnosed myeloma
-
2:06
long-term follow-up from the uk myeloma xi trial
-
4:48
overview of the final analysis of the phase iii tourmaline-mm1 trial
-
2:53
analysis of mrd conversion rates and the impact on survival outcomes in the myeloma forte trial
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
1:30
results of the ruxopeg trial: combining ruxolitinib and interferon in patients with myelofibrosis
-
1:56
defining the optimal duration of maintenance therapy for multiple myeloma
-
2:35
final analysis of the phase 2 centaurus study | ola landgren, md | ash 2023
-
2:02
evaluating the optimal duration of lenalidomide maintenance after autosct using data from myeloma xi